Display options
Share it on

J Physiol. 2004 May 15;557:307-19. doi: 10.1113/jphysiol.2004.063354. Epub 2004 Mar 19.

The effect of dehydroepiandrosterone on regional blood flow in prepubertal anaesthetized pigs.

The Journal of physiology

C Molinari, A Battaglia, E Grossini, D A S G Mary, C Vassanelli, G Vacca

Affiliations

  1. Laboratorio di Fisiologia, Dipartimento di Scienze Mediche, Facoltà di Medicina e Chirurgia, Università del Piemonte Orientale A. Avogadro, Novara, Italy. [email protected]

PMID: 15034120 PMCID: PMC1665037 DOI: 10.1113/jphysiol.2004.063354

Abstract

Dehydroepiandrosterone has been implicated in vascular disease and its associated insulin resistance and hypertension, though little is known about its vascular effects. We have recently shown in prepubertal anaesthetized pigs that intravenous infusion of dehydroepiandrosterone caused coronary vasoconstriction through the inhibition of a vasodilatory beta-adrenergic receptor-mediated effect related to the release of nitric oxide. The present study was designed to investigate the effect of dehydroepiandrosterone on mesenteric, renal and iliac vascular beds. In prepubertal pigs of both sexes anaesthetized with sodium pentobarbitone, changes in superior mesenteric, left renal and left external iliac blood flow caused by intravenous infusion of dehydroepiandrosterone were assessed using electromagnetic flowmeters. Changes in heart rate and arterial blood pressure were prevented by atrial pacing and by connecting the arterial system to a pressurized reservoir containing Ringer solution. In 22 pigs, infusion of 1 mg h(-1) of dehydroepiandrosterone decreased mesenteric, renal and iliac blood flow. In a further 10 pigs, dose-response curves were obtained by graded increases in the infused dose of hormone between 0.03 and 4 mg h(-1). The mechanisms of the above response were studied in the 22 pigs by repeating the experiment after haemodynamic variables had returned to the control values observed before infusion. Blockade of alpha-adrenoceptors with intravenous phentolamine (five pigs) did not affect the dehydroepiandrosterone-induced mesenteric, renal and iliac vasoconstriction. This response was abolished by blockade of beta(2)-adrenoceptors with intravenous butoxamine (five pigs) and by blockade of mesenteric, renal and iliac nitric oxide synthase with intra-arterial administration of N(omega)-nitro-L-arginine methyl ester (seven pigs), even after reversing the increase in local vascular resistance caused by the two blocking agents with intravenous infusion of papaverine. In five pigs, the increase in measured blood flow caused by intravenous infusion of isoproterenol (isoprenaline) was significantly reduced by infusion of dehydroepiandrosterone. The present study showed that intravenous infusion of dehydroepiandrosterone primarily caused mesenteric, renal and iliac vasoconstriction. The mechanisms of this response were shown to be due to the inhibition of a vasodilatory beta(2)-adrenergic receptor-mediated effect, which possibly involved the release of nitric oxide.

References

  1. Physiol Res. 2000;49 Suppl 1:S43-56 - PubMed
  2. Endocr J. 1999 Aug;46(4):521-8 - PubMed
  3. Exp Physiol. 2001 Jan;86(1):101-8 - PubMed
  4. J Vasc Res. 2001 Nov-Dec;38(6):569-77 - PubMed
  5. J Physiol. 2002 Aug 15;543(Pt 1):365-72 - PubMed
  6. Arch Med Res. 2002 Nov-Dec;33(6):524-30 - PubMed
  7. J Physiol. 2003 Jun 15;549(Pt 3):937-44 - PubMed
  8. Hepatogastroenterology. 2003 May-Jun;50(51):771-4 - PubMed
  9. J Clin Endocrinol Metab. 2003 Jul;88(7):3190-5 - PubMed
  10. J Vet Pharmacol Ther. 1981 Sep;4(3):183-91 - PubMed
  11. J Cardiovasc Pharmacol. 1985 Jan-Feb;7(1):139-44 - PubMed
  12. Am J Physiol. 1986 May;250(5 Pt 2):H892-7 - PubMed
  13. N Engl J Med. 1986 Dec 11;315(24):1519-24 - PubMed
  14. Br Heart J. 1991 Mar;65(3):116-25 - PubMed
  15. J Vasc Res. 1992 Jan-Feb;29(1):2-7 - PubMed
  16. FASEB J. 1992 Sep;6(12):3073-5 - PubMed
  17. Circulation. 1992 Nov;86(5):1529-35 - PubMed
  18. Circ Res. 1993 Aug;73(2):241-51 - PubMed
  19. Lancet. 1994 Jun 11;343(8911):1479-81 - PubMed
  20. Atherosclerosis. 1994 Feb;105(2):191-200 - PubMed
  21. Circulation. 1995 Mar 15;91(6):1757-60 - PubMed
  22. J Physiol. 1995 Jun 15;485 ( Pt 3):817-25 - PubMed
  23. Hypertension. 1995 Dec;26(6 Pt 2):1065-9 - PubMed
  24. Ann N Y Acad Sci. 1995 Dec 29;774:259-70 - PubMed
  25. Ann N Y Acad Sci. 1995 Dec 29;774:271-80 - PubMed
  26. Exp Physiol. 1996 May;81(3):385-96 - PubMed
  27. Atherosclerosis. 1996 Aug 23;125(1):1-13 - PubMed
  28. J Endocrinol. 1996 Sep;150 Suppl:S149-53 - PubMed
  29. Pediatr Res. 1997 Sep;42(3):273-81 - PubMed
  30. J Cardiovasc Pharmacol. 1997 Oct;30(4):523-7 - PubMed
  31. Scand Cardiovasc J Suppl. 1998;47:23-30 - PubMed
  32. Pflugers Arch. 1998 Jul;436(2):159-67 - PubMed
  33. J Physiol. 1999 Feb 1;514 ( Pt 3):875-84 - PubMed
  34. J Clin Pharmacol. 1999 Apr;39(4):327-48 - PubMed
  35. J Clin Epidemiol. 1999 Feb;52(2):95-103 - PubMed
  36. Steroids. 1999 Sep;64(9):640-7 - PubMed
  37. J Clin Endocrinol Metab. 2000 Sep;85(9):3208-17 - PubMed

Substances

MeSH terms

Publication Types